IRCT20161022030424N11RecruitingPhase 3
Effect of a medium-chain triglyceride (MCT)-Based Ketogenic Dietary Intervention along with high-dose intravenous ascorbic acid among overweight/obese patients with triple-negative breast cancer
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Recruiting
- Enrollment
- 240
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to 70 years (—)
- Sex
- All
Inclusion Criteria
- •18 to 70 years old
- •Pathologically confirmed early-stage triple-negative breast cancer subtype
- •1–3 positive axillary lymph nodes
- •Histological grades I-III
- •Unilateral cancer
- •A body mass index (BMI) of 25 kg/m2 and higher
Exclusion Criteria
- •Serious cardiovascular disease
- •Cognitive impairment
- •Metabolic defects as a contraindication against ketogenic diet
- •Who are considered unsuitable for the trial by the principal investigator because of abnormal blood indices or other reasons
- •Use of systemic corticosteroids within one week of trial entry
- •Receipt of chemotherapy within two week of trial entry
- •Prior monoclonal antibody therapy within 1 month of trial entry
Investigators
Similar Trials
Recruiting
Not Applicable
Preventing the neurotoxic effects of hypoglycaemia in adolescents with Type 1 diabetes- a randomised placebo-controlled trialType 1 diabetesACTRN12617000780358Murdoch Childrens Research Institute10
Recruiting
Not Applicable
The effect of intaking medium- chain triglycerides in dysphagia patientsJPRN-UMIN000029528Tokyo Medical and Dental University35
Recruiting
Phase 2
Confirmation of effects of medium chain triglyceride therapy for citrin deficiencycitrin deficiencyEndocrinology and Metabolism, PediatricsD006111JPRN-jRCTs041190017Mitsui Tetsuo50
Completed
Not Applicable
The Effects of Two Different Supplemental Oils on Keto-Adaptation and Symptoms of Carbohydrate WithdrawalObesityDiabetesACTRN12616001099415AUT University30
Recruiting
Not Applicable
Effect van MCT inname in gezonde personeNL-OMON25246Amsterdam UMC AMC4